Cardiovascular Drugs and Therapy

, Volume 7, Issue 5, pp 767–774

Lowering blood lipids to treat atherosclerosis: Vascular tone, plaques, events, and mortality

  • Paolo Rubba
  • Paolo Pauciullo
  • Mario Mancini
The Cholesterol Controversy Editorial

DOI: 10.1007/BF00878928

Cite this article as:
Rubba, P., Pauciullo, P. & Mancini, M. Cardiovasc Drug Ther (1993) 7: 767. doi:10.1007/BF00878928

Summary

Hypercholesterolemia has been associated with an increase in vascular tone, mainly because of an impairment of endothelium-dependent relaxation. This endothelial dysfunction occurs before any definite atherosclerotic lesion is demonstrated. In both animal models and humans the correction of hypercholesterolemia has been associated with hemodynamic improvement. Several controlled trials have demonstrated that long-term treatment with cholesterol-lowering drugs is effective in blocking progression and in some cases in inducing regression of angiographically detected arterial lesions. Arteriographies produce a negative image of the arterial lumen but do not provide sufficient information on vessel wall status. Noninvasive B-mode ultrasound has allowed a direct visualization of the arterial wall in superficial vascular districts, such as the carotid bifurcation. Wall and lesion measures are increasingly used as end points for clinical trials of antiatherosclerotic drugs. In secondary prevention, cholesterol reduction is associated with a lower incidence of coronary heart disease, although the cholesterol reduction should be at least 8–9% to have an impact on total mortality.

Key Words

atherosclerosischolesterolvascular toneoxidized lipoproteinsendothelium dependent relaxationlipid lowering drugscoronary heart diseaseangiographyultrasound

Copyright information

© Kluwer Academic Publishers 1993

Authors and Affiliations

  • Paolo Rubba
    • 1
  • Paolo Pauciullo
    • 1
  • Mario Mancini
    • 1
  1. 1.Institute of Internal Medicine and Metabolic Diseases, 2nd Medical SchoolUniversita “Federico II”NapoliItaly
  2. 2.Institute of Internal Medicine and Metabolic DiseasesUniversita “Federico II”NapoliItaly